S53 Prolactin Excess: Causes and Challenges

Program: Symposia
Clinical Session
Saturday, March 7, 2015: 9:30 AM-11:00 AM
Room 6A (San Diego Convention Center)
**This session is eligible for CME credit**

Chair:
Marcello D Bronstein, MD, PhD, University of São Paulo Medical School, São Paulo, Brazil

Nothing to Disclose: MDB Disclosure Not Provided: AAT

Prolactin is a pituitary hormone initially discovered for its role in lactating women. As the most common hormone over-secreted by pituitary adenomas, significant effort has gone into understanding Prolactin’s role as an endocrine hormone. As more information about this hormone and its receptor has been obtained, it has become clear that Prolactin’s role in physiology is much more complex than previously thought. In this seminar, three experts will discuss recent advances in understanding both the causes and the consequences of excess Prolactin and its multiple effects in the human body.

9:30 AM
Paul J Newey, Department of Cardiovascular and Diabetes Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee, Scotland
Nothing to Disclose: PJN
10:00 AM
Mônica R. Gadelha, MD, PhD, Internal Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Disclosure: MRG: Clinical Researcher, Pfizer, Inc..
10:30 AM
Dominique Maiter, MD, PhD, Endocrinology and Nurition, Univ of Louvain, Brussels, Belgium
Disclosure: DM: Speaker, Ipsen, Speaker, Novartis Pharmaceuticals, Speaker, Novo Nordisk, Speaker, Pfizer, Inc., Advisory Group Member, Novartis Pharmaceuticals.
See more of: Symposia